SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 12th, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 12th, 2021 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of October 7, 2021, by and between RESPIRERX PHARMACEUTICALS INC., a Delaware corporation, with headquarters located at 126 Valley Road, Suite C, Glen Rock, NJ 07452 (the “Company”), and DARIUSZ NASIEK and SARA NASIEK JTTEN, with an address at [***] (the “Buyer”).
COMMON STOCK PURCHASE WARRANT RESPIRERX PHARMACEUTICALS INC.Security Agreement • October 12th, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 12th, 2021 Company Industry JurisdictionThis COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the promissory note in the principal amount of $115,000.00 to the Holder (as defined below) of even date) (the “Note”), Dariusz Nasiek and Sara Nasiek JTTEN (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from RESPIRERX PHARMACEUTICALS INC., a Delaware corporation (the “Company”), 5,750,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated October 7, 2021, by and among the Company and the Holder (the
PIGGY-BACK REGISTRATION RIGHTS AGREEMENTPiggy-Back Registration Rights Agreement • October 12th, 2021 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 12th, 2021 Company Industry JurisdictionTHIS PIGGY-BACK REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of October 7, 2021, is made by and between RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”), and Dariusz Nasiek and Sara Nasiek, JTTEN (the “Holder”). The Company and the Holder are hereinafter sometimes collectively referred to as the “Parties” and each a “Party” to this Agreement.